CQSP in Malawi: Chloroquine and Sulfadoxine-pyrimethamine Efficacy for the Treatment of Malaria in Malawi

NCT00125489 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

210

Enrollment

NIH

Sponsor class

Conditions

Malaria
Plasmodium Falciparum Malaria

Interventions

DRUG: chloroquine sulfate
DRUG: sulfadoxine/pyrimethamine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)